RxSight (NASDAQ:RXST) Earns Buy Rating from Analysts at Needham & Company LLC
Needham & Company LLC assumed coverage on shares of RxSight (NASDAQ:RXST – Get Rating) in a research note published on Friday morning, Marketbeat Ratings reports. The brokerage issued a buy rating and a $18.00 price target on the stock. Separately, Zacks Investment Research lowered RxSight from a hold rating to a sell rating in a […]